Instadose Pharma Corp.

OTC: INSD · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Chesapeake, VA · Chesapeake (Independent City)CIK 0001697587Reports USD

#1131 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 12GM —SS 16

v0.1 · 25/100 weight · pillars only

↑ Piotroski F, Altman-Z · ↓ disclosure history, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$462.0k

Employees

Market cap

$53.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.7k$2.7k2018

Net income-$462.0k-$462.0k2021

Operating income-$106.4k-$106.4k2020

Total assets$0$02021

Equity-$162.3k-$162.3k2021

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Instadose Pharma Corp. booked $2.7k in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -17017.4% net margin.

Peers · Healthcare

BellRock Brands Inc.——Panbela Therapeutics, Inc.——Profusa, Inc. Common Stock9D Pineapple, Inc.——

Neighbors

Chesapeake (Independent City) →

Dollar Tree, Inc.$19.4B74B Greenwave Technology Solutions, Inc.$46.7M28D

Key facts

CEOAntonio Rocco Franchino

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersChesapeake, VA

ExchangeOTC: INSD

Employees2

IPO date2020-10-27

Latest filings

8-K2023-09-19 8-K2023-07-07 8-K2022-11-07 8-K2022-11-04 8-K2022-09-28 10-Q2022-05-09 10-K2022-03-15 8-K2022-02-23

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.